Dr Felix Mahfoud studied medicine at the Johann-Wolfgang-Goethe University, Frankfurt, Germany. He completed his residency at the Department of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany. He is associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital and Affiliate/Visiting Professor of the Harvard-MIT, Biomedical Engineering, Boston, MA.
Dr Mahfoud is a recipient of multiple national and international awards. His special scientific interest includes pathophysiology, conservative and novel interventional therapies of heart failure and hypertension. He is member of several editorial boards and serves as board member of the European Society of Cardiology Council on Hypertension‚ Working Group Interventional Hypertension Treatment of the European Society of Hypertension, EuroPCR Board of Directors, Co-Chairmen of the Resistant Hypertension Course Berlin, TCT Associate Director, and program committee member of the ESC congress 2015 & 2016.
Dr Mahfoud is involved as steering committee member in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.